Fundamentos de toxicología (40)

Prévia do material em texto

European Nordik Group. EU maximum le vels for dio-
xins and dioxin-lik e PCBs . 2008. http://norden.org/
pub/miljo/miljo/uk/TN2008531.pgf.
Evans, DAP, White TA. Human acetylation polymorp-
hism. J. Lab. Clin. Med. 1964. 63:394-401. 
Evans DAP. Genetic factors in drug therapy. In: Clinical
and Molecular Pharmacogenetics. Cambridge:
Cambridge University Press; 1993.
Flores J, Mediavilla A, Armijo JA (eds). Farmacología
humana, 4ª ed. Barcelona. Masson. 2003. 
Gilbert SF. Developmental Biology, 8ª ed., Sunderlan,
MA, EE.UU, Sinauer Ass. Inc. 2006. 
Hawksworth G, Hill MJ. The formation of nitrosamines by
human intestinal bacteria Biochem. J. 1971; 122, 28-30.
Hogson E, Guthrie FE. Introduction to biochemical
toxicology. Oxford: Blackwell Sc Pub. 1980.
IUPAC. Biological monitoring for exposure to volatile
compounds (VOCs). Pure Appl. Chem. 2000, 72, 3,
385-436.
Kolmodin B. Drugs interactions. New York: Raven
Press, 1974. 
Mounie J, Goudonnet H, Prevost C, Champion L, et al.
Nutritional factors of microsomal enzymatic induc-
tion : influence of lipidic components of the diet. Eur.
J. drug metab. pharmacokinet. 1990, 15, 4, 265-271
Pelkonen O, Kaltiala EH, Karki NT, Jalonen K, Pyorala
K. Properties of benzpyrene hydroxylase from
human liver and comparison with the rat, rabbit and
guinea-pig enzymes. Xenobiotica. 1975; 5(8):501-9 . 
Regoli F, Winston GW, Gorbi S, Frenzilli G, et al. Inte-
grating enzymatic responses to organic chemical
exposure with total oxyradical absorbing capacity and
dna damage in the european eel anguilla anguilla.
Environ. Toxicol. and Chem. 2007, 22, 9, 2120-2129.
Rose P, Whiteman M, Moore PK, Yi Zhun Zhu. Bioacti-
ve S-alk(en)yl cysteine sulfoxide metabolites in the
genus Allium: the chemistry of potential therapeutic
agents. Biological Psychiatry.1997,4,814-826.
Roth J, Hardison RD, James RC et al. Cocaine hepato-
toxicity: influence of hepatic enzime inducing and
inhibiting agents on the site of necrosis. Hepatho-
logy, 1992; 15, 5: 934-940. 
Salazar E, Pimentel E. Interacciones entre alimentos y
fármacos. Acta Odontológica venezolana, 2002, 40.
Sanders OT, Kirkpatrick RL. Effects of a polychlorina-
ted biphenyl (PCB) on sleeping times, plasma corti-
costeroids, and testicular activity of white-footed
mice. Environ Physiol Biochem. 1975;5(5):308-313.
Shao J, Zhou B, Zhu L, et al. In vitro characterization of
enzymatic properties and inhibition of the p53R2
subunit of human ribonucleotide reductase. Cancer
Research, 2004, 64,1-6. 
Shen WW. The metabolism of psychoactive drugs: A
review of enzymatic biotransformation and inhibi-
tion. Nat. Prod. Rep., 2005, 22, 351-368.
Smuckler EA, Arrhenius E, Hultin T. Alterations in
microsomal electron transport, oxidative N-demethy-
lation and azo-dye cleavage in carbon tetrachloride
and dimethylnitrosamine-induced liver injury. Bio-
chem J. 1967l; 103(1): 55-64. 
Whittaker, JA, Evans, D.A.P. Genetic control of phenyl-
butazone metabolism in. man. Brit. Med. J . 4, 323-
328 (1970).
World Health Organization. WHO-ECEH/IPCS; Con-
sultation on assessment of health risk of dioxins: re-
evaluation of daily toler able intake (TDI), Geneva:
WHO, 1998.
FENÓMENOS DE INHIBICIÓN, ACTIVACIÓN E INDUCCIÓN ENZIMÁTICAS 159
05 toxicologia alim 24/11/08 13:20 Página 159